Literature DB >> 19342991

Outfracture of the Inferior Turbinate: A Computed Tomography Study.

Fuat Buyuklu1, Ozcan Cakmak, Evren Hizal, Fuldem Yildirim Donmez.   

Abstract

BACKGROUND: Various surgical treatment modalities are available for inferior turbinate (IT) hypertrophy. Each is related with well-established complications, but still there is a lack of consensus on the optimal technique. Outfracture of the IT is thought to be a minimal destructive procedure among all other reductive turbinate interventions. Our aim was to assess the long term effects of IT outfracture technique in patients with mild or moderate IT hypertrophies.
METHODS: Twenty ITs in 10 patients were outfractured during a septoplasty procedure. The distance of the IT bone to the lateral nasal wall was compared at 3 different levels of the nasal passage before and after (at 9 months) surgery with computed tomography scans of each patient at (1) the first section in which the IT bone could be seen entirely (anterior portion), (2) the level of the maxillary sinus ostium (middle portion), (3) the last section in which the IT bone could be seen entirely (posterior portion).
RESULTS: A statistically significant degree of lateralization was observed at all levels in all patients. The mean lateralization rates were 15%, 26%, and 23% for the right side, and 26%, 29%, and 25% for the left side at first, second, and third levels, respectively. There was no bleeding, edema, or crusting due to the outfracture procedure in any patient.
CONCLUSIONS: Our results suggest that outfracture of the IT is an effective and durable technique, which can be performed easily to enlarge the nasal airway in mild and moderate IT hypertrophies with minimal morbidity.

Entities:  

Year:  2009        PMID: 19342991     DOI: 10.1097/PRS.0b013e31819b69b1

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  8 in total

1.  Comparison of Inferior Turbinate and Uncinate Process Angulation with Normal Population in Patients with Septal Spur.

Authors:  Hacer Baran; Elif Elibol; Adin Selcuk
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-04-16

Review 2.  [Nasal turbinate surgery].

Authors:  F Sommer; J Lindemann; M-O Scheithauer; T K Hoffmann; J A Veit
Journal:  HNO       Date:  2017-05       Impact factor: 1.284

3.  Investigating the effects of inferior turbinate outfracture on the lacrimal system by evaluating the results of paranasal sinus computed tomography and nasolacrimal irrigation test.

Authors:  Oğuzhan Dikici; Hafize Gökben Ulutaş; Gülçin Kazaz Dikici
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-09-19       Impact factor: 2.503

Review 4.  Advances in the surgical management of chronic sinusitis and nasal polyps.

Authors:  Vijay R Ramakrishnan; David W Kennedy
Journal:  Curr Allergy Asthma Rep       Date:  2011-06       Impact factor: 4.806

5.  The effects of inferior turbinoplasty on nasal airflow during cosmetic rhinoplasty.

Authors:  R Zojaji; M Keshavarzmanesh; M Bakhshaee; R Behdani; S Esmaeelzadeh; M MazloumFarsiBaf
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-04-29       Impact factor: 2.124

6.  Early clinical outcomes of ınferior turbinate radiofrequency and lateralization combined with septoplasty.

Authors:  Dursun Mehmet Mehel; Tuğba Yemiş; Mehmet Çelebi; Erkan Can; Doğukan Özdemir; Asude Ünal; Abdulkadir Özgür
Journal:  Braz J Otorhinolaryngol       Date:  2020-08-19

7.  Disease-specific quality of life after septoplasty and bilateral inferior turbinate outfracture in patients with nasal obstruction.

Authors:  Lucas Resende; Carolina do Carmo; Leão Mocellin; Rogério Pasinato; Marcos Mocellin
Journal:  Braz J Otorhinolaryngol       Date:  2017-07-29

8.  Effects of turbinoplasty versus outfracture and bipolar cautery on the compensatory inferior turbinate hypertrophy in septoplasty patients.

Authors:  Aykut Bozan; Hüseyin Naim Eriş; Denizhan Dizdar; Sercan Göde; Bahar Taşdelen; Hayrettin Cengiz Alpay
Journal:  Braz J Otorhinolaryngol       Date:  2018-05-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.